The forecasted data for breast cancer screening coverage in France shows a consistent decline from 2024 to 2028. Starting at 47.2% in 2024, coverage slightly decreases each year, reaching 46.4% by 2028. This represents a gradual yet persistent downtrend in screening coverage, with a year-on-year decrease that underscores a need for interventions to reverse this trend. The average annual decrease over these five years suggests that despite the accessibility and advancements in healthcare, there are underlying factors that could be contributing to this decline.
Looking forward, it’s critical to monitor factors such as policy changes, healthcare access, public awareness campaigns, and technological advancements in screening methodologies. Enhancing public awareness and improving access could be key strategies to halt or reverse the declining trend in breast cancer screening coverage in France.
